#1 Clinical Trials Search in Europe

L-Ascorbic Acid

L-Ascorbic Acid, commonly known as Vitamin C, is being studied in clinical trials for its potential benefits in treating various medical conditions. These trials are exploring its use in COVID-19, gestational diabetes, acute myeloid leukemia, myelodysplastic syndromes, and acute lung injury. Researchers are investigating different administration methods, dosages, and their effects on patient outcomes, safety, and efficacy.

Table of Contents

What is L-Ascorbic Acid?

L-Ascorbic Acid, commonly known as Vitamin C, is an essential nutrient that plays a crucial role in many bodily functions. It is a powerful antioxidant, meaning it helps protect cells from damage caused by harmful molecules called free radicals. In recent years, researchers have been exploring its potential therapeutic uses beyond its well-known role in preventing scurvy (a disease caused by vitamin C deficiency)[1][2].

Medical Conditions Being Studied

Scientists are investigating the use of L-Ascorbic Acid in treating various medical conditions. Some of the areas being researched include:

  • COVID-19 and Acute Lung Injury: Researchers are studying whether high doses of intravenous vitamin C can help patients with severe COVID-19 infections[1][4].
  • Gestational Diabetes: Studies are looking at how vitamin C supplementation might affect pregnant women with gestational diabetes and their babies[2].
  • Acute Myeloid Leukemia and Myelodysplastic Syndromes: Researchers are exploring how manipulating vitamin C levels might affect these blood disorders[3].

Research on COVID-19 and Lung Injury

Two clinical trials are investigating the use of high-dose intravenous vitamin C (HDIVC) in patients with COVID-19:

1. One study is looking at whether HDIVC can help prevent the progression of COVID-19 to more severe forms, such as Acute Respiratory Distress Syndrome (ARDS). ARDS is a serious lung condition that causes difficulty breathing. The researchers hope that giving vitamin C early in the disease course might reduce inflammation and prevent patients from needing mechanical ventilation (breathing machines)[1].

2. Another study is examining the safety of giving high doses of vitamin C to patients with COVID-19 who have low oxygen levels. This study is also looking at how vitamin C affects various markers of inflammation in the body[4].

Gestational Diabetes Research

Gestational diabetes is a type of diabetes that occurs during pregnancy. A study is investigating whether giving 1 gram of oral vitamin C daily to pregnant women with gestational diabetes can help improve outcomes for both the mother and baby. The researchers are particularly interested in how vitamin C might affect oxidative stress, which is an imbalance between harmful free radicals and antioxidants in the body[2].

Leukemia and Myelodysplastic Syndrome Research

An interesting study is looking at how changing vitamin C levels in the body might affect certain blood cancers, specifically Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS). The researchers found that some cancer cells might depend on vitamin C for growth. They are exploring whether lowering vitamin C levels could potentially be used as a treatment for these conditions[3].

How is L-Ascorbic Acid Administered?

In these studies, L-Ascorbic Acid is being administered in different ways:

  • Intravenous (IV) infusion: For COVID-19 studies, high doses (50 mg/kg every 6 hours) are given directly into the bloodstream through an IV[1][4].
  • Oral supplementation: In the gestational diabetes study, participants take 1 gram of vitamin C by mouth daily[2].
  • Cyclic administration: In the leukemia study, researchers are alternating between periods of vitamin C depletion and supplementation[3].

Safety and Potential Side Effects

While vitamin C is generally considered safe, these studies are carefully monitoring for any potential side effects, especially when given in high doses. Some of the things researchers are watching for include:

  • Kidney problems, such as kidney stones or acute kidney injury
  • Changes in blood sugar levels
  • Pain or swelling at the infusion site
  • Changes in certain blood tests

It’s important to note that these are controlled clinical trials, and patients should not attempt to replicate these treatments at home. Always consult with a healthcare provider before starting any new supplement regimen[1][4].

Aspect Details
Conditions Studied COVID-19, Gestational Diabetes, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lung Injury
Administration Methods Intravenous infusions, Oral supplementation
Dosages Varies by study: 50 mg/kg IV every 6 hours (COVID-19), 1 gram oral daily (Gestational Diabetes)
Treatment Duration 4 days to several months, depending on the study
Primary Outcomes Safety, tolerability, efficacy, changes in disease status
Secondary Outcomes Changes in inflammatory markers, ventilator-free days, mortality rates, oxidative stress parameters
Safety Monitoring Renal function, oxalate levels, adverse events

FAQ

  • What conditions are being studied using L-Ascorbic Acid in clinical trials? Clinical trials are exploring the use of L-Ascorbic Acid (Vitamin C) in various conditions, including COVID-19, gestational diabetes mellitus, acute myeloid leukemia, myelodysplastic syndromes, and acute lung injury.
  • How is L-Ascorbic Acid administered in these trials? The administration methods vary depending on the study. Some trials use intravenous infusions of high-dose Vitamin C, while others use oral supplementation. For example, in COVID-19 studies, intravenous infusions of 50 mg/kg every 6 hours are being used, while in gestational diabetes, oral doses of 1 gram per day are being tested.
  • What are the potential benefits of L-Ascorbic Acid in COVID-19 treatment? Researchers hypothesize that high-dose intravenous Vitamin C may reduce the risk of respiratory failure requiring mechanical ventilation, development of acute respiratory distress syndrome (ARDS), and may help decrease supplemental oxygen demand and inflammatory markers in COVID-19 patients.
  • Are there any safety concerns with using high doses of L-Ascorbic Acid? Safety is a primary concern in these trials. Researchers are monitoring for potential adverse events such as acute kidney injury, hemolysis, and crystalluria. In the COVID-19 study, renal safety biomarkers like serum and urine oxalate levels are being closely monitored.
  • How long do the L-Ascorbic Acid treatments typically last in these trials? The duration of treatment varies by study. For instance, in the COVID-19 trial, the treatment lasts for 4 days (96 hours), while in the gestational diabetes study, Vitamin C is given from the time of diagnosis until delivery. In the leukemia study, cyclic application of supplementation and depletion is being tested.

Ongoing Clinical Trials on L-Ascorbic Acid

  • Study on the Effect of Vitamin C and Microcrystalline Cellulose on Reducing Complex Regional Pain Syndrome in Patients Undergoing Upper Limb Surgery

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Acute Myeloid Leukemia (AML): A type of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells.
  • Myelodysplastic Syndromes (MDS): A group of disorders where blood-forming cells in the bone marrow become abnormal, leading to low blood cell counts.
  • Gestational Diabetes Mellitus: A form of high blood sugar that develops during pregnancy and can affect the health of both the mother and baby.
  • Acute Respiratory Distress Syndrome (ARDS): A serious lung condition that causes fluid to build up in the air sacs, leading to severe breathing difficulties.
  • Hypoxemia: A below-normal level of oxygen in the blood, specifically in the arteries.
  • Intravenous (IV): Administered directly into a vein.
  • Oxidative Stress: An imbalance between free radicals and antioxidants in the body, which can lead to cell and tissue damage.
  • Biomarkers: Measurable indicators of the presence or severity of a disease state.
  • Crystalluria: The presence of crystals in urine, which can be a sign of kidney problems or medication side effects.
  • Scurvy: A disease caused by severe Vitamin C deficiency, characterized by swollen gums, bleeding, and weakness.

References

  1. https://clinicaltrials.gov/study/NCT04357782
  2. https://clinicaltrials.gov/study/NCT02355197
  3. https://clinicaltrials.gov/study/NCT00329498
  4. https://clinicaltrials.gov/study/NCT04344184